PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.21%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
8.31%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
25.60%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
27.07%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
40.70%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
40.71%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
40.71%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.58%
10Y revenue/share CAGR under 50% of 2127.T's 302.48%. Michael Burry would suspect a lasting competitive disadvantage.
-16.43%
Negative 5Y CAGR while 2127.T stands at 153.37%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
39.52%
3Y revenue/share CAGR at 75-90% of 2127.T's 52.27%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.54%
Net income/share CAGR at 50-75% of 2127.T's 238.83%. Martin Whitman might question if the firm’s product or cost base lags behind.
26.35%
Below 50% of 2127.T's 98.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
62.87%
3Y net income/share CAGR above 1.5x 2127.T's 3.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
172.32%
Below 50% of 2127.T's 378.28%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
21.13%
Below 50% of 2127.T's 162.16%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.38%
3Y equity/share CAGR similar to 2127.T's 62.85%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-25.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
50.00%
Below 50% of 2127.T's 860.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
38.46%
Below 50% of 2127.T's 405.26%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
23035.00%
Our AR growth while 2127.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.52%
Inventory shrinking or stable vs. 2127.T's 52.74%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.02%
Asset growth above 1.5x 2127.T's 3.05%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.55%
1.25-1.5x 2127.T's 4.20%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
1.97%
We have some new debt while 2127.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-46.41%
We cut SG&A while 2127.T invests at 34.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.